Navigation Links
The Children's Hospital of Philadelphia and BGI Announce Partnership and New Joint Genome Center to Target Pediatric Diseases
Date:11/9/2011

PHILADELPHIA and CAMBRIDGE, Mass., Nov. 9, 2011 /PRNewswire-USNewswire/ -- The Children's Hospital of Philadelphia and BGI, the world's largest genomics institute, today announced they have formed a partnership, BGI@CHOP, to conduct large-scale human genome sequencing and bioinformatics analysis at a newly established, state-of-the-art Joint Genome Center at Children's Hospital. The partnership will focus on the discovery of genes underpinning rare and common pediatric diseases using next-generation sequencing. The Center became fully operational last month.

The BGI@CHOP partnership will bring together the unique strengths of two world-class institutions. BGI's capabilities and expertise in whole genome sequencing and analysis, combined with Children's Hospital's extensive biobank and expertise in clinical phenotyping, will allow scientists and clinicians to harness the power of large, detailed data sets to improve the lives of patients and families.

"The Children's Hospital of Philadelphia has built the largest pediatric biobank in the world, and because many of these samples have been linked to clinical data using an electronic medical record, we can now follow disease processes into adulthood," said Hakon Hakonarson, M.D., Ph.D., Director of the Center for Applied Genomics at Children's Hospital. "Through our partnership with BGI, we now have a clear path forward into the genomics-based personalized medicine arena."

"We are very excited about this new partnership with BGI," said Philip Johnson, M.D., Chief Scientific Officer at The Children's Hospital of Philadelphia.  "It is an ideal collaboration between two world-class institutions. The ultimate goal is to change the way we diagnose and treat diseases that affect children and families, and our work with BGI is an important first step toward that end."

"This new partnership will accelerate the discovery of genetic variants underpinning rare and common pediatric diseases by j
'/>"/>

SOURCE The Children's Hospital of Philadelphia
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology news :

1. Childrens Hospital LA discovers growth factor essential to epicardial cell function
2. Study: Residential washers may not kill hospital-acquired bacteria
3. Researchers at Cruces Hospital describe new syndrome of slight family intellectual disability
4. Thomas Jefferson University Hospital adopts new automated laboratory
5. Mass. Eye and Ear awarded largest NIH grant in hospital’s history
6. Childrens hospitals not equipped to handle pandemics
7. Wireless network in hospital monitors vital signs
8. UH Rainbow Babies and Childrens Hospital opens asthma studies
9. A*Star scientists discover how to combat hospital-acquired infections and life-threatening toxins
10. Research provides insight into new drug resistance in hospital microbes
11. NIH awards $17 million Program of Excellence Award in glycosciences to Brigham and Womens Hospital
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... DUBLIN , June 25, 2015 ... the addition of the "Next Generation Biometrics Market ... to 2020" report to their offering. ... $24.4 Billion by 2020, at a CAGR of 17.9% ... is the leading application for the market. Safran ...
(Date:6/30/2015)... To bolster its efforts and commitment to fighting cyber fraud, ... of two new team members. Dimitri ... Raviv will act as head of strategic alliances. These ... the most secure solutions for the enterprise market. ... a provider of security and management products, which was acquired ...
(Date:6/29/2015)... DUBLIN , June 24, 2015 ... the addition of the "Latin America Biomedical Sensors ... to their offering. The Latin America Biomedical ... at a CAGR of 2.04% over the period 2014-2020 ... that are adaptable to the genetic formulation of each ...
Breaking Biology News(10 mins):Next Generation Biometrics Market 2015 - Global Forecast to 2020 with Safran, NEC, 3M Cogent, Fujitsu & Suprema Dominating the $24 Billion Market 2Next Generation Biometrics Market 2015 - Global Forecast to 2020 with Safran, NEC, 3M Cogent, Fujitsu & Suprema Dominating the $24 Billion Market 3HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 2HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 3Latin America Biomedical Sensors Market Report 2015-2020 2
... Two Latina mothers are heroes in the new comic ... School of Nursing at Case Western Reserve University. Their quest ... families and combat obesity. The cartoon moms are like ... about the growing obesity problem among young children, says Jill ...
... building blocks of RNA originated on Earth, guanine -- the ... to be a particular challenge. While the other three bases ... -- could be created by heating a simple precursor compound ... not been observed as a product of the same reactions. ...
... 14th, 2010 Concern about microbial contamination of groundwater ... practices in New Zealand have increased over the years. ... are commonly found in cow manure. Addressing the lack ... Zealand researchers studied the transport of microbes from two ...
Cached Biology News:Comic book moms are nutrition heroes to guide migrant family health 2Study shows adding UV light helps form 'Missing G' of RNA building blocks 2Study shows adding UV light helps form 'Missing G' of RNA building blocks 3
(Date:8/3/2015)... , Aug. 3, 2015  Aethlon Medical, Inc. (Nasdaq: ... to treat life-threatening diseases, today announced that it will ... and webcast on Thursday, August 13, 2015 at 4:30 ... will follow the release of fiscal 2016 first quarter ... available approximately two hours after the call at the ...
(Date:8/3/2015)... August 3, 2015 According to ... 3D Cell Culture: Asia to ... Research, the global 3D cell culture market was valued at US$ ... at a CAGR of 29.1% to account for US$ ... with TOC:  http://www.persistencemarketresearch.com/market-research/3d-cell-cultures-market.asp 3D cell culture ...
(Date:7/31/2015)... VEGAS , July 31, 2015 ... seek resources that help them drive positive health ... a vital source of patient care in their ... annual tradeshow and conference, AmerisourceBergen announced a ... its Pharmacy Services Administration Organization and help independent ...
(Date:7/31/2015)... ... , ... R-Biopharm is proud to announce the RIDASCREEN® Gliadin ... has been accepted by AOAC International as Official First Action method. The AOAC ... by R5 Competitive ELISA,” based on a specific monoclonal antibody to potentially celiac ...
Breaking Biology Technology:Aethlon Medical To Host First Quarter Fiscal 2016 Investor Call on August 13, 2015 2Global 3D Cell Culture Market Will Reach US$ 2,717.6 Million by 2020: Persistence Market Research 2Global 3D Cell Culture Market Will Reach US$ 2,717.6 Million by 2020: Persistence Market Research 3Global 3D Cell Culture Market Will Reach US$ 2,717.6 Million by 2020: Persistence Market Research 4AmerisourceBergen Unveils Suite of Enhanced Capabilities for Independent Pharmacies at ThoughtSpot 2015 2AmerisourceBergen Unveils Suite of Enhanced Capabilities for Independent Pharmacies at ThoughtSpot 2015 3RIDASCREEN® Competitve Gliadin Receives AOAC Official First Action Status 2
... , LUMBY, BC, July 2 /PRNewswire-FirstCall/ - avVaa ... a global biotechnology company, manufacturer and distributor of ... products, announced the engagement of Koeppel Direct to ... Campbell-Farley, President/COO of avVaa World Health Care is ...
... July 2 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. (TSX: ONC, ... enrolment has been completed in the Phase II component ... with paclitaxel/carboplatin for patients with advanced cancers. The principal ... The Institute of Cancer Research, London, England, and Dr. ...
... analysis technique that identifies and removes systematic bias, ... lead to more precise and reliable measurement of ... applications. Known as sequential profile adjustment by ... amount of experimental data required to make conclusions, ...
Cached Biology Technology:avVaa World Health Care Products, Inc. Announces Engagement of Koeppel Direct for their DRTV-Direct Response Television Media Buying Campaign 2Oncolytics Biotech(R) Inc. Completes Patient Enrolment in U.K. Combination REOLYSIN(R) and Paclitaxel/Carboplatin Head and Neck Cancer Trial 2New statistical technique improves precision of nanotechnology data 2New statistical technique improves precision of nanotechnology data 3New statistical technique improves precision of nanotechnology data 4
Recombinant Mouse TGF-beta RII/(human) Fc Chimera, CF...
Phospho-TAO2 (S181) Affinity Purified Polyclonal Ab Protein Family: Other Intracellular Kinases...
Human Norrin Biotinylated Affinity Purified PAb Protein Family: Other Growth Factors, Other Wnt-related Molecules...
PEG 8000, Molecular Biology Grade...
Biology Products: